ArticleAmerican journal of translational research2024
Efficacy of moisture chamber goggles combined with fluorometholone eye drops on visual function and oxidative stress in patients with dry eye disease.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the effects of Moisture Chamber Goggles combined with Fluorometholone eye drops on visual function and oxidative stress in patients with dry eye disease.
methodsA retrospective analysis was conducted on 80 patients with dry eye disease treated at Ninghai First Hospital from January 2021 to May 2023. Patients were divided into a combination group (n=40, receiving Fluorometholone eye drops and Moisture Chamber Goggles) and a monotherapy group (n=40, receiving Fluorometholone eye drops alone) based on treatment regimens. Outcomes compared between the groups included subjective symptom scores (VAS), tear film stability parameters, inflammatory markers, oxidative stress indicators, and adverse reaction rates before and after treatment.
resultsPost-treatment, the combination group showed significantly longer tear breakup time (BUT) and higher Schirmer's test values compared to the monotherapy group (both P<0.05). Levels of tumor necrosis factor-α and metalloproteinase-2 were significantly lower in the combination group (P<0.05). Additionally, the combination group had significantly lower VAS scores, Ocular Surface Disease Index (OSDI) scores, and conjunctival hyperemia grades, as well as higher tear meniscus height and National Eye Institute Visual Function Questionnaire (VFQ-25) scores (all P<0.05). No significant differences in the incidence of adverse reactions were observed between the two groups (P>0.05).
conclusionThe combination of Moisture Chamber Goggles and Fluorometholone eye drops significantly improves subjective visual quality, promotes tear secretion, stabilizes the tear film, and reduces inflammatory and oxidative stress markers in patients with dry eye disease, while maintaining a favorable safety profile.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.